Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries’ arm - Caraco Pharmaceutical Laboratories, has initiated a recall of multiple lots of Cephalexin capsules from the US market. The recall of the 340,553 units of 500 mg and 113,677 units of 250 mg bottles is voluntarily initiated by the company through a letter to USFDA in June under ‘Class-II’ classification.

Cephalexin is an antibiotic that belongs to the family of medications known as cephalosporins. It is used to treat certain types of bacterial infections.

Class II recall is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.